Medical Technology Market Reports from MedMarket Diligence, LLC

Ablation Technologies Worldwide Market, 2008-2017

patrick@mediligence.com — Sun, 24 Aug 2008 11:15:05 -0700

Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies Markets, Companies and Opportunities

225 pages 60 Exhibits 61 Company Profiles Publishing August 2008 Report #A125

This report is a detailed market and technology assessment and forecast of the products and technologies in the ablation market for treatment of soft tissues via energy-based modalities, including electrosurgery, radiosurgery, gamma knife, brachytherapy, cryogenic therapy, fluidjet therapy (hydrotherapy), microwave ablation, radiofrequency ablation, laser, thermal ablation, and ultrasonic ablation. The report describes the energy-based technologies in terms of the nature of their effect on soft tissue, the underlying basis of the technology, the requisite systems for their use (including capital equipment, devices and disposables), and their strengths and weaknesses for specific clinical applications. The report details current and anticipated target applications and assesses the current and forecast caseload for each energy-based therapeutic considering competition from any and all alternative energy-based or other therapeutics for the following clinical areas: General surgery, Cardiac, Gynecologic, Orthopedic. The report presents current and worldwide market forecasts (2008-2017) segmented by technology type and specific clinical segment. The report also provides regional segmentation of the caseload; e,g., USA, Japan, Europe, RoW. The report will details the current and emerging products, technologies and markets for each energy-based therapy. The report profiles key companies in this industry detailing their current products, current market position and products under development.

See description, detailed table of contents at link.

The report may be ordered via the online store (save $1,500 pre-publication) or via PDF order form attached or at this link.

Tags: medtech, ablation,

Spine Surgery Worldwide, 2008-2017: Products, Technologies, Markets and Opportunities

patrick@mediligence.com — Mon, 7 Jan 2008 15:54:01 -0800

January 2008. "Spine Surgery Worldwide, 2008-2017: Products, Technologies, Markets and Opportunities"

This report is a detailed market and technology assessment and forecast of the products and technologies in the management of diseases and disorders of the spine. The report describes diseases and disorders of the spine, encompassing congenital disorders, inflammatory and infectious diseases; degenerative diseases; herniations, stenoses, myelopathies and other "mechanical" disorders of the spine; spinal trauma; tumors of the spine; and others. The report characterizes the patient populations, their current clinical management, and trends in clinical management as new techniques and technologies are expected to be developed and emerge. The report details the currently available products and technologies, and manufacturer offerings. The report details products and technologies under development and markets for each in spine surgery. The report provides a current and forecast assessment of the worldwide markets for these technologies, with geographic segmentation by U.S. & Canada, European Union (detailing France, United Kingdom, Germany, Italy and Spain), Japan and Rest of World. The report provides emphasis on the market impact of new technologies through the coming decade, profiling over 75 active companies in this industry, with comprehensive detail on key companies, providing data on their current products, current market position and products under development.

See a complete list of MedMarket Diligence Reports.

Tags: medtech, spine, artificial-disc, interbody-fusion.

Worldwide Wound Management, 2007-2016

patrick@mediligence.com — Mon, 3 Dec 2007 10:33:06 -0800

Published November 2007. "Worldwide Wound Management, 2006-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World."

This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments -- multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments.

See a complete list of MedMarket Diligence Reports.

Tags: medtech, wounds, wound-management, sutures, dressings, bandages

Worldwide Market for the Clinical Management of Obesity, 2007-2015

patrick@mediligence.com — Thu, 20 Sep 2007 09:11:50 -0700

Published September 2007. "Worldwide Market for the Clinical Management of Obesity" is a detailed market and technology assessment and forecast of the products and technologies in the clinical management of obesity. The report describes the current and projected patient population in obesity, detailing their incidence in the U.S., Europe, and Rest of World, and the clinical practices in obesity management encompassing surgical approaches, medical supervised severely restricted diets, drug therapies, OTC treatments, biopharmaceuticals, non-pharmacologic approaches and weight maintenance approaches. The report describes clinical trends in the management of the obese.

The report details the products on the market and the status of those in development for bariatric surgery, drug therapy, gastric stimulation devices, brain stimulation devices, combination therapies and genetic therapy, and provides current and forecast of the market for these products in the U.S., Europe and Rest of World. The report profiles key companies in the market, detailing the current products, products in development, market position and overall businesses in obesity management.

See a complete list of MedMarket Diligence Reports.

Tags: medtech, obesity, bariatric

Nearly 500 medical technology startups online

patrick@mediligence.com — Thu, 24 May 2007 10:54:16 -0700

May 2007.  Medical Technology Startups Database:  Technology Startups in the Medical Product Industry, An Online Searchable Database.

MedMarket Diligence's focus on advanced medical technologies regularly identifies newly founded medical product companies (including "stealth" companies seeking to shield their innovations from view) and publishes the relevant details in its MedMarkets publication and its syndicated market and technology Reports.

Now, the details of these new medtech companies are accessible in an online database available from MedMarket Diligence.  Data includes all available contact details, technology/company descriptions and categorization by clinical/technology focus.  The companies are also tracked and updated as new developments take place.

For more details, see this link.

Tags: medtech, startups

Worldwide Surgical Sealants, Glues & Wound Closure Market, 2007-2011

patrick@mediligence.com — Tue, 28 Nov 2006 08:26:05 -0800

Publishing December 2006. This report details the complete range of sealants & glues technologies, from tapes, sutures and staples to hemostats, fibrin sealants/glues and medical adhesives. The report examines the clinical and technology developments underlying this huge and rapidly growing worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

This report is a global market and technology assessment of established and emerging products in wound closure. The report details the current and emerging products, technologies and markets involved in wound closure and sealing using sutures and staples, tapes, hemostats, fibrin and sealant products and medical adhesives. The report provides a worldwide current and annual forecast to 2011 of the markets for these technologies, with particular emphasis on the market impact of new technologies through the coming decade. The report provides specific forecasts and market shares for the U.S., Europe (United Kingdom, German, France, Italy, BeNeLux), Latin America, Japan and Rest of World.

The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or sub-specialties vying for patient population and facilitating or limiting the growth of technologies.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

See a complete list of MedMarket Diligence Reports.

Tags: medtech, sealants, fibrin, cyanoacrylate, suture

Products, Technologies, Markets and Opportunities in Ophthalmic Surgical, Device and Drug Markets Worldwide, 2007

patrick@mediligence.com — Sat, 16 Sep 2006 12:48:29 -0700

Publishing October 2006. This report details worldwide the incidence and prevalence by country/region of vision disorders (myopia, hyperopia, presbyopia, glaucoma, cataracts and retinal disease), and details the current and projected market for diagnostic and therapeutic products in the management of these vision disorders, including general vision diagnostics, diagnostics for glaucoma, corneal and retinal disorders, and therapeutic options for these disorders including use of pharmaceuticals, surgery and devices. The report details current products and technologies in use and the status of development of novel products under development. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor share data are presented for the U.S., individual western European countries (UK, Germany, France, BeNeLux, Italy and Spain), Japan and other key international markets; Asia (India, Korea, Australia, Russia and China), the Americas (Canada, Mexico, Brazil) and South Africa category. The report profiles a minimum of 100 companies, with equitable inclusion or exclusion of specific companies based on consistent criteria. The company profiles provide detailed information on 10-15 major competitors, and brief profiles of companies with less sizeable current or potential positions in the market and additional profiles of companies with noteworthy novel or advanced research activities in the market.

The report establishes the market size for key international markets (as indicated above) for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market (shifts in share based on technology) as technologies gain or lose relative market performance over this period.

See a complete list of MedMarket Diligence Reports.

Tags: medtech, orthopedic, biomaterials

Spine Surgery Market, Worldwide

patrick@mediligence.com — Wed, 23 Aug 2006 06:16:54 -0700

The MedMarket Diligence report on spine surgery is a worldwide medical market and technology assessment of the products, technologies, and companies in the market for spine surgical technologies for the treatment of congenital spine disorders, inflammatory and infectious diseases of the spine, degenerative spine diseases, mechancial disorders of the spine (herniation, stenosis, myelopathy, etc.), spinal trauma and tumors of the spine. Technologies addressed include the range of traditional "open" surgical procedures (fusion, corpectomy, foraminotomy, laminectomy, etc.) and minimally invasive procedures (vertebroplasty/kyphoplasty, microscoopic discectomy, disc decompression, endoscopic scoliosis surgery, minimally invasive bone grafting, etc.), as well as the full range of other device and osteobiologic technologies being applied or developed. Detailed market data and forecasts for the U.S., Europe, Asia and ROW.

Other reports from MMD: nanotech/MEMS, diabetes, wound management, tissue engineering

See a complete list of MedMarket Diligence Reports.

Tags: medtech, orthopedic, biomaterials

Orthopedic Biomaterials 2006: Trends, Technologies and Opportunities in the Markets for Orthopedic Biomaterials Worldwide

patrick@mediligence.com — Tue, 22 Aug 2006 10:24:51 -0700

Publishing Sept/Oct 2006. This report is a detailed assessment of products and technologies in orthopedic biomaterials under development and on the market, including bone graft substitutes (including allografts), spinal machined bone, ceramic implants, bioresorbable fixation products (including polymers), hyaluronic acid viscosupplementation, growth factors, platelet concentration systems, surgical glues and sealants, anti-adhesive products, and tissue engineering products. The report addresses the major pathologies requiring surgical intervention (e.g., trauma, degenerative diseases of hip, knee and spine, etc); the most common and most important surgical procedures, with caseload detailed globally and regionally; the range of products available and their role in the various surgical procedures; trends in surgical practice, especially as they affect product uptake; description of the range of product types and specific products in current use; discussion of product trends, including changing market expectations leading research towards new products; and discussion of the main factors driving the market, and those inhibiting growth; the regulatory environment and its evolution; market size and growth, globally and regionally (USA, Europe, Japan, RoW) for 2006; market breakdown by main product types; leading companies and their market shares; five-year market forecasts (2007-11); and company profiles of the largest and/or most important companies.

See a complete list of MedMarket Diligence Reports.

Tags: medtech, orthopedic, biomaterials

Leverage your knowledge of medtech. Business report authors wanted.

Fri, 28 Jul 2006 08:58:47 -0700

MedMarket Diligence is seeking qualified authors to produce business reports on advanced medical technologies. Ideal prospective author has 10-15 years experience in business development, marketing/sales or other senior management in medical technology companies, as well as demonstrable research, analysis and writing skills. Contractual terms commensurate with balance of skills, experience.

Submit your details here. Fax resume/CV to 949-837-4558.

Tags: medtech

Recent Medical Technology Market Reports

patrick@mediligence.com — Fri, 28 Jul 2006 08:58:43 -0700

Recent market reports on advanced medical technologies from MedMarket Diligence:

Micro- and Nanomedicine 2006, published May 2006, price $2,950 print or PDF, more details

Startups 2006, published March 2006, price $495 PDF, more details

Diabetes Management, Worldwide, 2005-2015, published February 2006, price $2,950 print or PDF, more details

U.S. Market for Virtual Reality in Surgery, price $2,950 print or PDF, more details

Worldwide Wound Management, 2005-2014, price $3,750 print or PDF, more details

See a complete list of MedMarket Diligence Reports.

Tags: medtech

Micro- and Nanomedicine 2006: Technologies, Applications, Industry and Markets Worldwide

patrick@mediligence.com — Fri, 28 Jul 2006 08:58:36 -0700

May 2006. The Micro- and Nanomedicine report is MedMarket Diligence's current assessment of the status of development in both micro-electro-mechanical systems (MEMS) devices and nanotechnology applied to clinical applications, ranging from the emerging to those in early stages of development, but excluding the purely speculative. Applications assessed for their current status of development include: "Trojan Horse" drug delivery in cancer, liposome-encapsulated drug delivery, incorporation of MEMS in pacemaker accelerometers, nanoparticles in drug delivery, targeted drug delivery in cancers, gold nanoshells for heat-killing of cancer cells, cancer diagnostics, sensors for continuous blood glucose monitoring, MEMS in implantable pumps (e.g., insulin pumps), nanosensors to detect airborne pathogens, and the early stage applications of nano-batteries for artificial retinas, artificial viruses as gene carriers, MEMS in hearing aids and defibrillators and applications in biomedical research (DNA/RNA/protein analysis, lab-on-a-chip, etc.).

The report's focus is on providing a detailed status assessment of the range of medical applications of nanotech and MEMS, with analysis of global markets, segmented by U.S., Europe, Japan and Rest of World.

See a complete list of MedMarket Diligence Reports.

Tags: medtech, nanotech, MEMS

The U.S. and Western European Markets for Bone Graft Substitutes

patrick@mediligence.com — Wed, 4 Jan 2006 15:01:17 -0700

Published June 2005. The U.S. and Western European Bone Graft report provides a detailed overview of current bone graft substitute product and technology developments, with analysis of the trends, developments and market forecast. The report identifies market drivers, restraints and technological and business issues that will impact the bone graft substitutes market.

See a complete list of MedMarket Diligence Reports.

Tags: medtech, orthopedic, bone

Diabetes Management Market, Worldwide, 2005-2015

patrick@mediligence.com — Fri, 28 Jul 2006 08:58:28 -0700

Published December 2005. This report details the worldwide incidence and prevalence by country/region of Type 1 and Type 2 diabetes mellitus and details the current and projected market for diagnostic and therapeutic products in the management of diabetes, including anti-diabetic drugs, alternative insulin types, blood glucose monitoring (including continuous monitoring devices), insulin pumps, and other established and emerging products in diabetes management. The report provides an emphasis of detail on the status of development of novel products including noninvasive monitoring, oral/inhaled/other insulin delivery. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor share data are presented for the U.S., individual western European countries (Belgium, Denmark, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom), and Japan. The report profiles active companies including detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and appropriate additional profiles of companies with novel or advanced research activities in the market.

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and project the composition of the market as technologies gain or lose relative market performance over this period.

See a complete list of MedMarket Diligence Reports.

Tags: medtech, nanotech, diabetes, glucose, insulin

U.S. Market for Virtual Reality in Surgery & Imaging, 2004-2009

patrick@mediligence.com — Fri, 28 Jul 2006 08:58:24 -0700

Published, October 2005. This report details the products, markets and technology developments in virtual reality in surgery and imaging. Products and technologies are detailed in their current status of development, features, and applications, with coverage including 3D graphic modeling, texture mapping, dynamic generators, application programming, rendering, input peripherals and output peripherals. Applications addressed include those in radiology, neurosurgery, otolaryngology, cardiovascular surgery, obstetrics and gynecology, orthopaedic surgery, general surgery and oncology. The report provides a U.S. market assessment, with forecast to 2009, for virtual reality systems in surgical training, 3D diagnostic imaging, 3D visualization for telemedicine, pre-surgical planning, computer-aided surgery, and telesurgery. The report also profiles, with current products, products under development, evaluation of market strength, and other relevant information, the major companies currently or potentially active in this arena.

See a complete list of MedMarket Diligence Reports

Tags: medtech, surgery, virtual reality, telepresense, imaging

Worldwide Wound Management, 2005: Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World

patrick@mediligence.com — Fri, 28 Jul 2006 10:33:20 -0700

Published July 2005. This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is given to advanced or leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments such as conventional dressings markets. The report details the clinical and technology developments underlying this huge and evolving worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor share data are presented for the U.S., individual western European countries (UK, Germany, France, BeNeLux, Italy and Spain), Japan and and the Rest of World category. The report profiles 67 key companies (large and/or promising).

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.

See a complete list of MedMarket Diligence Reports.

Tags: medtech, wound, dressings, sutures

Tissue Engineering & Cell Therapy, Worldwide

patrick@mediligence.com — Wed, 13 Apr 2005 09:30:54 -0700

This report examines the status of technologies, applications and markets for tissue engineering, cell therapy and tissue/cell transplantation. The report reviews therapeutic tissue engineering, tissue reconstruction, cell therapies, tissue/organ transplantation and related technologies under various stages of development at over 150 companies. The report details the technology development, projected market introduction dates and/or current and forecast market size and competitor shares for products being developed to address major causes of death and disease spanning applications in cardiovascular, neurological, orthopaedic, urological, skin, organ and others. The report details the status of product development and assesses the current and forecast worldwide market for tissue engineering, cell therapy and transplantation.

See a complete list of MedMarket Diligence Reports

Worldwide Surgical Sealants, Glues & Wound Closure, 2004-2014

patrick@mediligence.com — Mon, 31 Jan 2005 12:54:32 -0700

This report details the complete range of sealants & glues technologies, from tapes, sutures and staples to hemostats, fibrin sealants/glues and medical adhesive. The report examines the clinical and technology developments underlying this huge and rapidly growing worldwide market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.

Published January 2005.

See a complete list of MedMarket Diligence Reports.

Cardiovascular Disease: A Review of Biomarkers, Surrogate Endpoints and Therapeutic Options

patrick@mediligence.com — Thu, 28 Oct 2004 09:08:16 -0700

This report is a detailed review of the range of current and emerging biomarkers used in the diagnosis and ongoing evaluation of atherosclerotic disease, the evaluation of the clinical impact of candidate pharmacologics and the evaluation of the impact of pharmacologics in the routine clinical management of atherosclerotic disease. The report also examines the underlying pathologies and the relationships between a variety of associated disease states (metabolic syndrome, obesity, dyslipidemias, diabetes, hypertension, cardiovascular disease, atherosclerosis, and coagulopathies. The report examines the range of cardiovascular therapeutics including those currently on the market and those under development, detailing the clinical considerations that impact the relative effectiveness in therapeutics and in the alternative biomarkers' ability to reveal the clinical benefits of these therapeutics.

Published October 2004

See a complete list of MedMarket Diligence Reports.

Products, Technologies and Markets in the Clinical Management of Obesity

patrick@mediligence.com — Fri, 22 Oct 2004 14:54:32 -0700

This report is a detailed market and technology assessment and forecast of the products and technologies in the clinical management of obesity. The report describes the current and projected patient worldwide population in obesity, detailing their incidence, the clinical practices in their management to encompass surgical approaches, medical supervised severely restricted diets, drug therapies, OTC treatments, biopharmaceuticals, non-pharmacologic approaches and weight maintenance approaches. The report describes clinical trends in the management of the obese. The report will detail the products on the market and the status of those in development for bariatric surgery, drug therapy, gastric stimulation devices, brain stimulation devices, combination therapies and genetic therapy, and provides current and forecast of the market for these products worldwide. The report profiles 34 companies in this market, detailing the current products, products in development, market position and overall businesses in obesity management.

Published October 2004

See a complete list of MedMarket Diligence Reports.

Top Volume Cardiovascular Procedures

patrick@mediligence.com — Thu, 16 Dec 2004 10:40:32 -0700

This report presents detailed inpatient and outpatient procedure data on the highest volume cardiovascular procedures. The data in this report has been an invaluable component of MedMarket Diligence's cardiovascular device technology analyses, and is now available as a separate report.

The report presents a ranking of the top cardiovascular procedures by volume, with detailed data from Medicare, the National Hospital Discharge Survey, the Healthcare Cost and Utilization Project, Data is presented on discharges by payer (Medicare, Medicaid, Blue Cross/Blue Shield, other private insurance, self-pay, no charge, uninsured, other), age group (85) and U.S. geographic region (midwest, northeast, south, west).

Published December 2004

See a complete list of MedMarket Diligence Reports.

European Cardiac Surgeon Perspectives on Practices and Products in Coronary Artery Bypass Grafting

patrick@mediligence.com — Thu, 23 Sep 2004 03:21:34 -0700

This Clinical Insight Brief is a summary and presentation of findings from interviews with 25 European cardiac surgeons regarding their current practices, caseload and perspectives in the performance of coronary artery bypass grafting (CABG), as well as their opinions on emerging practices and technologies for CABG including the use of off-pump (also known as "beating heart") bypass, minimally invasive direct coronary artery bypass (MIDCAB) and the specific products available or under development by manufacturers for these purposes. Direct phone interviews were held with cardiac surgeons in August/September 2004.

Published September 2004

See a complete list of MedMarket Diligence Reports.

Products, Systems and Opportunities in Heart Failure Management

patrick@mediligence.com — Mon, 3 May 2004 09:48:36 -0700

This report is a thorough assessment of the current and emerging clinical practice, products and systems for the prevention, screening, diagnosis and management of heart failure. The report details the incidence and prevalence of heart failure, projecting the trend as a result of demographics, intervention or other changes to the population of patients. The report details the current approaches applied by physicians (primary care & cardiologists) and healthcare systems to heart failure. The report addresses clinician and system approaches, detailing the practices, products, and services in use and under development. Products addressed include monitoring, medicines/drugs and devices. The report provides a detailed review of heart failure programs in place through disease management companies, and hospital, home care and outpatient programs. The report details the status of research toward improving heart failure programs. The report details the market outlook for products in heart failure management encompassing diagnostics, monitoring products, drugs/medicines and devices.

Published April 2004.

See a complete list of MedMarket Diligence Reports.